Treace Medical Concepts (TMCI) Operating Expenses (2020 - 2026)

Treace Medical Concepts' Operating Expenses history runs 7 years deep, the most recent figure standing at $54.6 million for Q1 2026.

• Quarterly Operating Expenses fell 5.05% year-over-year to $54.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $221.0 million (changed 0.21% YoY) and the FY2025 annual result came in at $223.9 million, changed 0.02% from the prior year.
• Operating Expenses was $54.6 million for Q1 2026 at Treace Medical Concepts, down from $56.3 million in the prior quarter.
• Across five years, Operating Expenses topped out at $59.9 million in Q1 2024 and bottomed at $32.0 million in Q1 2022.
• A 5-year average of $50.4 million and a median of $54.6 million in 2026 frame the typical range for Operating Expenses.
• Annual changes were most pronounced in 2022 — Operating Expenses surged 90.76% — and 2026, when it retreated 5.05%.
• Treace Medical Concepts' Operating Expenses stood at $44.2 million in 2022, then jumped by 30.01% to $57.5 million in 2023, then declined by 3.21% to $55.7 million in 2024, then increased by 1.15% to $56.3 million in 2025, then declined by 3.11% to $54.6 million in 2026.
• Business Quant data shows TMCI's Operating Expenses at $54.6 million in Q1 2026, $56.3 million in Q4 2025, and $55.4 million in Q3 2025.